Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31409364 | 0.86 | HTR6 (0.30) | ELANE | |
| SCHEMBL20329007 | 0.82 | HTR2A (0.35) | MEN1GABRA1CYP2C19GABRB2KMT2A | |
| SCHEMBL24303590 | 0.76 | CHRM3 (0.31) | — | |
| SCHEMBL16220577 | 0.73 | MEN1 (0.34) | MEN1GABRA1CYP2C19GABRB2KMT2A | |
| SCHEMBL20333664 | 0.72 | CHRM5 (0.33) | — | |
| SCHEMBL19042352 | 0.72 | MEN1 (0.33) | MEN1GABRA1CYP2C19GABRB2KMT2A | |
| SCHEMBL16380132 | 0.72 | MEN1 (0.33) | MEN1GABRA1CYP2C19GABRB2KMT2A | |
| SCHEMBL3337356 | 0.72 | PDCD1 (0.35) | MEN1GABRA1CYP2C19GABRB2KMT2A | |
| Hydrochloric Acid SCHEMBL15021048 | 0.70 | PDCD1 (0.35) | MEN1GABRA1CYP2C19GABRB2KMT2A | |
| SCHEMBL19131408 | 0.69 | CHRNB2 (0.35) | MEN1GABRA1CYP2C19GABRB2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038920-A1 | HETEROARYL AMINE COMPOUNDS AND USES THEREOF | XENON PHARMACEUTICALS, INC. (CA) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025038917-A1 | HETEROARYL AMINE COMPOUNDS AND USES THEREOF | XENON PHARMACEUTICALS INC. (CA) | 2025-02-20 | — | — | WO | disclosed |